Craniopharyngiomas invading the ventricular system: A systematic review Review


Authors: Palmisciano, P.; Young, K.; Ogasawara, M.; Yousefi, O.; Ogasawara, C.; Ferini, G.; Bin-Alamer, O.; Sharma, M.; Umana, G. E.; Yu, K.; Cohen-Gadol, A. A.; El Ahmadieh, T. Y.; Haider, A. S.
Review Title: Craniopharyngiomas invading the ventricular system: A systematic review
Abstract: Background/Aim: Craniopharyngiomas involving the ventricular system are rare but pose significant surgical challenges. We systematically reviewed the literature on craniopharyngiomas invading the ventricles (CP-V). Materials and Methods: PubMed, EMBASE, Scopus, Web of Science, and Cochrane were searched to include studies reporting clinical data of patients with CP-Vs. Clinico-radiological features, management, and treatment outcomes were analyzed. Results: We included 73 studies encompassing 407 patients. Patients were mostly male (61.5%), presenting with headache (57.9%) and/or endocrine disorders (52.1%). CP-Vs mostly involved the third ventricle (96.3%), followed by the lateral ventricles (2.9%), and the fourth ventricle (1%). Tumors had cystic components in 59% of cases and were mostly adamantinomatous (70.8%). Open resection was performed in 232 cases (57%), mostly with trans-lamina terminalis (36.6%) and trans-callosal (31.9%) approaches. Endoscopic resection was performed in 169 cases (41.5%), mostly with trans-sphenoidal (74.6%) and transventricular (24.9%) approaches. Gross-total tumor resection was obtained in most cases (62.9%). Adjuvant radiotherapy was delivered in 22.8% cases. A total of 178 patients experienced persistent complications, mostly including diabetes insipidus (47.1%) and panhypopituitarism (12.7%), not significantly different after open versus endoscopic resection (p=0.117). Symptom improvement was obtained in 88% of cases. CP-Vs recurrences were reported in 94 patients (23.1%), with median progression-free survival of 13.5 months (range=0.5-252.0 months). Fifty-nine patients died (14.5%), with median overall survival of 32.0 months (range=0.5-252.0 months), significantly longer after endoscopic resection than open resection (p=0.019). Conclusion: CP-Vs are uncommon and challenging entities. Surgical resection is feasible, but patient-tailored selection of open/endoscopic approaches is necessary to achieve optimal outcomes and minimize complication risks. © The author(s).
Keywords: adolescent; adult; child; treatment outcome; aged; cancer surgery; retrospective studies; overall survival; review; follow up; progression free survival; pathology; retrospective study; brain ventricle; systematic review; endoscopic surgery; headache; craniopharyngioma; skull base; adjuvant radiotherapy; visual impairment; endocrine disease; hydrocephalus; cerebral ventricles; brain fourth ventricle; complication; hypophysis tumor; hypopituitarism; brain third ventricle; neuro-oncology; diabetes insipidus; pituitary neoplasms; adamantinomatous craniopharyngioma; intraventricular tumor; brain lateral ventricle; humans; human; male; female
Journal Title: Anticancer Research
Volume: 42
Issue: 9
ISSN: 0250-7005
Publisher: International Institute of Anticancer Research  
Date Published: 2022-09-01
Start Page: 4189
End Page: 4197
Language: English
DOI: 10.21873/anticanres.15919
PUBMED: 36039438
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 3 October 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kenny Kwok Hei Yu
    32 Yu